AGG’s Food and Drug Team and Corporate Practice Group invites you to participate in the following complimentary webinar:
“Effective FCPA Compliance: An Ounce of Prevention…”
being held Wednesday, November 9, 2011 11:30 am – 1:00 pm EDT. In this 90-minute webinar Michael E. Burke, partner in the Corporate Practice Team, will discuss how over the past few years, the U.S. Justice Department has significantly increased the number, and scope, of investigations and prosecutions under the Foreign Corrupt Practices Act (FCPA). Pharmaceutical companies remain a focus area for FCPA compliance. Penalties, both civil and criminal, are higher than ever, as are the reputational and other risks.
If you have any questions please contact Tracey Chapman, Event Coordinator at firstname.lastname@example.org.
The U.S. Justice Department has significantly increased the number and scope of investigations and prosecutions under the Foreign Corrupt Practices Act (FCPA).
Civil and criminal penalties are higher than ever, as are reputational and other risks. Pharmaceutical companies remain an area of focus for FCPA compliance.
AGG Partner Michael E. Burke has put together a free webinar on what pharmaceutical companies need to know so as not to run afoul of the FCPA. The webinar, “Effective FCPA Compliance: An Ounce of Prevention…,” provides an update on FCPA investigations and reviews compliance best practices.
Mr. Burke chairs the American Bar Association’s 25,000-member Section of International Law.
In addition to advising on FCPA compliance, Mr. Burke assists clients in complying with U.S. export controls regulations, U.S. economic sanctions programs, and U.S. anti-boycott regulations. He also advises on privacy, data protection and information security issues in the U.S. and abroad.
Mr. Burke is an editor and co-author of the Corporate Counsel’s Guide to Doing Business in China, 3d, 2012 ed., and is the United States Country Councillor for LAWASIA (The Law Association for Asia and the Pacific).